<?xml version="1.0" encoding="UTF-8"?>
<ref id="bb0405">
 <label>81</label>
 <element-citation publication-type="journal" id="rf0400">
  <person-group person-group-type="author">
   <name>
    <surname>Widjaja</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>van Haperen</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Gutiérrez-Álvarez</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>van Dieren</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Okba</surname>
    <given-names>N.M.A.</given-names>
   </name>
  </person-group>
  <article-title>Towards a solution to MERS: protective human monoclonal antibodies targeting different domains and functions of the MERS-coronavirus spike glycoprotein</article-title>
  <source>Emerg Microbes Infec</source>
  <volume>8</volume>
  <year>2019</year>
  <fpage>516</fpage>
  <lpage>530</lpage>
  <pub-id pub-id-type="doi">10.1080/22221751.2019.1597644</pub-id>
  <pub-id pub-id-type="pmid">30938227</pub-id>
 </element-citation>
</ref>
